婴儿无晶状体眼研究:10年随访青光眼相关不良事件分析
该研究基于婴儿无晶状体眼研究(IATS)114例单侧先天性白内障婴儿的随机临床试验,分析至10.5岁时青光眼及青光眼疑似事件的发生率与视觉结局。Kaplan-Meier分析显示,所有术眼青光眼风险从1年时的9%升至10年时的22%,青光眼+疑似风险从12%升至40%,且与是否一期植入IOL无关。10岁时青光眼眼轴较长但RNFL相对保留,视力与无青光眼眼相似。
要点
- 单侧先天性白内障术后10年青光眼累积风险22%,青光眼+疑似风险40%。
- 青光眼风险随时间持续上升,且与一期IOL植入无显著关联。
- 10岁时青光眼眼轴较长,但RNFL相对保留、视盘外观和视力相似。
核心结论
- 单侧先天性白内障婴儿术后青光眼相关不良事件风险随随访延长持续增加,且与一期IOL植入无关。
- 术后发生青光眼或疑似青光眼与10岁时视力结局较差无关。
研究设计与样本
- 多中心随机临床试验的二次分析,纳入114例手术时年龄1至6个月的单侧先天性白内障婴儿。
- 参与者随机接受一期IOL植入或无晶状体眼(接触镜)治疗,在10.5岁时收集长期青光眼相关状态和结局数据。
主要发现
- 所有术眼(n=114)青光眼风险从1年时的9%(95%CI 5%-16%)升至5年时的17%(95%CI 11%-25%),再升至10年时的22%(95%CI 16%-31%)。
- 青光眼+疑似青光眼诊断风险从1年时的12%(95%CI 7%-20%)升至5年时的31%(95%CI 24%-41%),再升至10年时的40%(95%CI 32%-50%)。
- 10年时青光眼和青光眼+疑似诊断风险在治疗组间无显著差异。
- 与青光眼疑似或两者均无的眼相比,青光眼眼轴较长,但RNFL相对保留,视盘外观和10岁时视力相似。
关键数值与推荐
- IATS制定了青光眼和青光眼疑似的标准化定义,用于监测和诊断。
- 主要结局指标包括术眼至10.5岁时青光眼和青光眼+疑似青光眼的发生,以及眼压、眼轴、RNFL(OCT)和视盘照片。
临床怎么用
- 单侧先天性白内障术后需长期监测青光眼相关事件,风险持续至10岁以后。
- 一期IOL植入未增加10年时青光眼相关风险,选择术式时可参考。
- 术后发生青光眼或疑似青光眼不一定预示10岁时视力结局更差。
局限性
- 本研究为随机临床试验的二次分析。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Glaucoma-related adverse events constitute serious complications of cataract removal in infancy, yet long-term data on incidence and visual outcome remain lacking. OBJECTIVE: To identify and characterize incident cases of glaucoma and glaucoma-related adverse events (glaucoma + glaucoma suspect) among children in the Infant Aphakia Treatment Study (IATS) by the age of 10.5 years and to determine whether these diagnoses are associated with optic nerve head (ONH) and peripapillary retinal nerve fiber layer (RNFL) assessment. DESIGN, SETTING, AND PARTICIPANTS: Analysis of a multicenter randomized clinical trial of 114 infants with unilateral congenital cataract who were aged 1 to 6 months at surgery. Data on long-term glaucoma-related status and outcomes were collected when children were 10.5 years old (July 14, 2015, to July 12, 2019) and analyzed from March 30, 2019, to August 6, 2019. INTERVENTIONS: Participants were randomized at cataract surgery to either primary intraocular lens (IOL), or aphakia (contact lens [CL]). Standardized definitions of glaucoma and glaucoma suspect were created for IATS and applied for surveillance and diagnosis. MAIN OUTCOMES AND MEASURES: Development of glaucoma and glaucoma + glaucoma suspect in operated-on eyes up to age 10.5 years, plus intraocular pressure, axial length, RNFL (by optical coherence tomography), and ONH photographs. RESULTS: In Kaplan-Meier analysis, for all study eyes combined (n = 114), risk of glaucoma after cataract removal rose from 9% (95% CI, 5%-16%) at 1 year, to 17% (95% CI, 11%-25%) at 5 years, to 22% (95% CI, 16%-31%) at 10 years. The risk of glaucoma plus glaucoma suspect diagnosis after cataract removal rose from 12% (95% CI, 7%-20%) at 1 year, to 31% (95% CI, 24%-41%) at 5 years, to 40% (95% CI, 32%-50%) at 10 years. Risk of glaucoma and glaucoma plus glaucoma suspect diagnosis at 10 years was not significantly different between treatment groups. Eyes with glaucoma (compared with eyes with glaucoma suspect or neither) had longer axial length but relatively preserved RNFL and similar ONH appearance and visual acuity at age 10 years. CONCLUSIONS AND RELEVANCE: Risk of glaucoma-related adverse events continues to increase with longer follow-up of children following unilateral cataract removal in infancy and is not associated with primary IOL implantation. Development of glaucoma (or glaucoma suspect) after removal of unilateral congenital cataract was not associated with worse visual acuity outcomes at 10 years. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00212134.
引用
- Freedman SF, Beck AD, Nizam A, et al. Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021. PMID: 33331850. doi:10.1001/jamaophthalmol.2020.5664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。